Description
The project will involve the expansion of the Enki platform capabilities to incorporate additional high value biological property prediction functionality to enable the development of truly novel kinase inhibitors.
Amendment chain · 3 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $300,000 at start, $400,000 after amendment #2 (+$100,000).
- #02024-04-01$300,000
- #12024-10-28$350,000+$50,000
- #22025-02-06$400,000+$50,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2024-04-01(start date) | $300,000 | — | The project will involve the expansion of the Enki platform capabilities to incorporate additional high value… |
| #1 amendment | 2024-10-28 | $350,000 | +$50,000 | The project will involve the expansion of the Enki platform capabilities to incorporate additional high value… |
| #2 amendment | 2025-02-06 | $400,000 | +$50,000 | The project will involve the expansion of the Enki platform capabilities to incorporate additional high value… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 773532932)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2026-2027-Q1-1041790 | National Research Council Canada | Conseil national de recherches Canada · CanExport | $35,000 | FY2027 |
| 033-2025-2026-Q4-515697 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · AI Compute Access Fund | $3,117,381 | FY2026 |
| 172-2025-2026-Q2-1034048 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $5,000 | FY2026 |
| 033-2023-2024-Q4-FR-33755 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · Canadian Digital Adoption Program Boost your Business Technology Stream | $15,000 | FY2024 |
| 172-2022-2023-Q3-999571 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $281,243 | FY2023 |
| 172-2022-2023-Q3-997337 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $22,125 | FY2023 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2024-2025-Q1-1017553 · retrieved 2026-11-12.